At Miami Cancer Institute we are dedicated to finding new and better ways to treat cancer through research and clinical trials. We have access to clinical trials through our affiliation with the US Oncology Research Network, directly through Pharma trials and via our affiliation with the National Cancer Institute’s CTSU program. Through our clinical trials program we are at the forefront of advancing the latest developments in investigational drugs, new methods of care and reducing side effects. Participating in these clinical trials also allows us to provide valuable access to new investigational cancer agents to people right here in our community.
Furthermore, our research network is also looking toward the future by developing initiatives in “personalized” or “individualized” medicine. These types of clinical trials offer the potential to recommend drug treatment based on an individual’s genetic background.